Background Image
Table of Contents Table of Contents
Previous Page  45 / 66 Next Page
Information
Show Menu
Previous Page 45 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 3, May/June 2021

AFRICA

155

in urban African adults: insights from the Heart of Soweto Study.

Eur

Heart J

2010:

31

(6): 719–72.

2.

Zühlke LJ, Engel ME, Watkins D, Mayosi BM. Incidence, prevalence and

outcome of rheumatic heart disease in South Africa: A systematic review

of contemporary studies.

Int J Cardiol

2015;

199

: 375–383.

3.

Gaasch WH. Pathophysiology and natural history of chronic mitral

regurgitation.

https://www.uptodate.com/contents/pathophysiology-and-

natural-history-of-chronic-mitral-regurgitation.

4.

Bonow RO, Carabello BA, Chatterjee K, De Leon AC, Faxon DP,

Freed MD,

et al.

ACC/AHA 2006 guidelines for the management of

patients with valvular heart disease: a report of the American College

of Cardiology/American Heart Association Task Force on Practice

Guidelines (writing Committee to Revise the 1998 guidelines for the

management of patients with valvular heart disease) developed in collab-

oration with the Society of Cardiovascular Anaesthesiologists endorsed

by the Society for Cardiovascular Angiography and Interventions and

the Society of Thoracic Surgeons.

J Am Coll Cardiol

2006; 48(3): e1–48.

5.

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ,

et

al

. 2017 ESC/EACTS guidelines for the management of valvular heart

disease

. Eur Heart J

2017:

38

(36): 2739–2791.

6.

Prakaschandra DR, Naidoo DP, Esterhuizen T. The time-course changes

of NT-proBNP and tissue Doppler indices in patients undergoing mitral

valve replacement.

Cardiovasc J Afr

2012;

23

(4): 200.

7.

Griffin BP. Timing of surgical intervention in chronic mitral regurgita-

tion: is vigilance enough?

Circulation

2006;

113

(18): 2169–217.

8.

Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D,

Szymanski C,

et al

. Survival implication of left ventricular end-systolic

diameter in mitral regurgitation due to flail leaflets: a long-term follow-up

multicenter study.

J Am Coll Cardiol

2009:

54

(21): 1961–1968.

9.

Lang RM, Badano LP, Mor-Avi V,

et al

. Recommendations for cardi-

ac chamber quantification by echocardiography in adults: an update

from the American Society of Echocardiography and the European

Association of Cardiovascular Imaging.

Eur Heart J

Cardiovasc Imag

2015;

16

: 233–270.

10. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K,

et al

.

World Heart Federation criteria for echocardiographic diagnosis of

rheumatic heart disease- an evidence-based guideline.

Nat Rev Cardiol

2012;

9

: 297–309.

11. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD,

Levine RA,

et al

. Recommendations for evaluation of the severity of

native valvular regurgitation with two-dimensional and Doppler echocar-

diography.

J Am Soc Echocardiogr

2003;

16

(7): 777–802.

12. Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart

disease.

Circulation

2005;

112

: 3584–3591.

13. Zuhlke L, Engel ME, Karthikeyan G,

et al

. Characteristics, complica-

tions, and gaps in evidence-based interventions in rheumatic heart

disease: the Global Rheumatic Heart Disease Registry (the REMEDY

study).

Eur Heart J

2015;

36

: 1115–1122a.

14. Munasur M. The outcome of patients undergoing simultaneous tricuspid

and left-sided valve surgery in a rheumatic population.

J Heart Valve Dis

2016;

25

(1): 1–7.

15. Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ,

et

al.

Recovery of left ventricular function after surgical correction of mitral

regurgitation caused by leaflet prolapse.

J Thorac Cardiovasc Surg

2009;

137

(5): 1071–1076.

16. Reed D, Abbott RD, Smucker ML, Kaul S. Prediction of outcome after

mitral valve replacement in patients with symptomatic chronic mitral

regurgitation. The importance of left atrial size.

Circulation

1991:

84

(1):

23–24.

17. Kennedy JW, Yarnall SR, Murray JA, Figley MM. Quantitative angiog-

raphy, IV: relationships of left atrial and ventricular pressure and volume

in mitral valve disease.

Circulation

1970;

41

: 817– 824.

18. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD,

Bailey KR,

et al

. Echocardiographic prediction of left ventricular func-

tion after correction of mitral regurgitation: results and clinical implica-

tions.

J Am Coll Cardiol

1994;

24

(6): 1536–1543.

19. Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ,

et al

.

Determinants of early decline in ejection fraction after surgical correction

of mitral regurgitation.

J Thorac Cardiovasc Surg

2008;

136

(2): 442–447.

20. Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation

– implications for management.

Circulation

2008;

118

: 2298–2303.

21. Hultgren HN, Miyagawa M, Buch W, Angell WW. Ischemic myocardial

injury during cardiopulmonary bypass surgery.

Am Heart J

1973:

85

(2):

167–176.

22. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-

Sarano M. Burden of valvular heart diseases: a population-based study

.

Lancet

2006;

368

(9540): 1005–1011.

23. Marcus RH, Sareli P, Pocock WA, Meyer TE, Magalhaes MP, Grieve T,

et

al.

Functional anatomy of severe mitral regurgitation in active rheumatic

carditis.

Am J Cardiol

1989;

63

(9): 577–584.

24. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe

rheumatic mitral valve disease in a developing country: correlations

among clinical presentation, surgical pathologic findings, and hemody-

namic sequelae.

Ann Int Med

1994;

120

(3): 177–183.

25. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve

replacement for rheumatic mitral regurgitation in the era of chordal pres-

ervation.

Circulation

1994;

89

: 191–197.

26. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation.

Lancet

2009;

373

: 1382–1394.

27. Suri RM, Vanoverschelde JL, Grigioni F, Schaff HV, Tribouilloy C,

Avierinos JF,

et al.

Association between early surgical intervention vs

watchful waiting and outcomes for mitral regurgitation due to flail mitral

valve leaflets.

J Am Med Assoc

2013;

310

(6): 609–616.

28. Stevens L-M, Rodriguez E, Lehr EJ, Kindell LC, Nifong LW, Ferguson

TB,

et al

. Impact of timing and surgical approach on outcomes after

mitral valve regurgitation operations.

Ann Thorac Surg

2012:

93

(5):

1462–1468.

29. Matsumura T, Ohtaki E, Tanaka K,

et al

. Echocardiographic prediction

of left ventricular dysfunction after mitral valve repair for mitral regur-

gitation as an indicator to decide the optimal timing of repair.

J Am Coll

Cardiol

2003;

42

: 458–463.

30. Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena

HI,

et al

. Prognostic and therapeutic implications of pulmonary hyper-

tension complicating degenerative mitral regurgitation due to flail leaflet:

a multicenter long-term international study.

Eur Heart J

2010;

32

(6):

751–759.

31. Lancellotti P, Martinez C, Bernard A. Pulmonary pressures and outcome

in primary mitral regurgitation.

J Am Coll Cardiol

2016:

67

(25):

2962–2964.

32. Ghoreishi M, Evans CF, DeFilippi CR, Hobbs G, Young CA, Griffith

BP,

et al

. Pulmonary hypertension adversely affects short- and long-term

survival after mitral valve operation for mitral regurgitation: implications

for timing of surgery.

J Thorac Cardiovasc Surg

2011:

142

(6): 1439–1452.

33. Magne J, Pibarot P, Sengupta PP, Donal E, Rosenhek R, Lancellotti P.

Pulmonary hypertension in valvular disease: a comprehensive review on

pathophysiology to therapy from the HAVEC Group.

J Am Coll Cardiol

Img

2015:

8

(1): 83–99.

34. Enriquez-Sarano M, Orszulak TA, Schaff HV, Abel MD, Tajik AJ, Frye

RL. Mitral regurgitation: a new clinical perspective.

Mayo Clinic Proc

1997;

72

(11): 1034–1043.